ARVN
Arvinas, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C
Company Profile
CEO
Randy Teel
IPO Date
2018-09-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Arvinas, Inc.
CEO
Randy Teel
IPO Date
2018-09-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 22,714 |
| $8.05 |
| 26 Jun 2026 | Norwalk Leslie V | director | A-Award | Acquired | 15,527 | $0.00 |
| 26 Jun 2026 | Norwalk Leslie V | director | A-Award | Acquired | 22,714 | $8.05 |
| 26 Jun 2026 | Morrison Briggs | director | A-Award | Acquired | 15,527 | $0.00 |
| 26 Jun 2026 | Morrison Briggs | director | A-Award | Acquired | 22,714 | $8.05 |
| 26 Jun 2026 | Kennedy Edward Moore Jr. | director | A-Award | Acquired | 15,527 | $0.00 |
| 26 Jun 2026 | Kennedy Edward Moore Jr. | director | A-Award | Acquired | 22,714 | $8.05 |
| 26 Jun 2026 | Cunningham Everett | director | A-Award | Acquired | 15,527 | $0.00 |
| 26 Jun 2026 | Cunningham Everett | director | A-Award | Acquired | 22,714 | $8.05 |